Pages that link to "Q35408613"

The following pages link to Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling (Q35408613):

Displaying 31 items.

• Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder (Q30840162) (← links)
• A Fine Balance of Synaptophysin Levels Underlies Efficient Retrieval of Synaptobrevin II to Synaptic Vesicles (Q35922182) (← links)
• Monitoring activity-dependent bulk endocytosis with the genetically-encoded reporter VAMP4-pHluorin (Q36938949) (← links)
• Recent advances in genetics of chorea (Q37069506) (← links)
• ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects (Q37153019) (← links)
• The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease (Q37307728) (← links)
• Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders. (Q37508181) (← links)
• SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond. (Q38726283) (← links)
• Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets (Q39164408) (← links)
• Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. (Q40089319) (← links)
• Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease. (Q40607068) (← links)
• A synaptotagmin suppressor screen indicates SNARE binding controls the timing and Ca2+ cooperativity of vesicle fusion. (Q41671800) (← links)
• Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome. (Q41836213) (← links)
• Emerging Monogenic Complex Hyperkinetic Disorders. (Q44707117) (← links)
• Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease (Q44909742) (← links)
• Altered synaptobrevin-II trafficking in neurons expressing a synaptophysin mutation associated with a severe neurodevelopmental disorder. (Q45826766) (← links)
• Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex (Q47222228) (← links)
• Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD. (Q50684186) (← links)
• Presynaptic disorders: a clinical and pathophysiological approach focused on the synaptic vesicle (Q57175515) (← links)
• Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons (Q57812775) (← links)
• SYT1-associated neurodevelopmental disorder: a case series (Q58194861) (← links)
• Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia (Q64039544) (← links)
• Congenital myasthenic syndromes (Q64102614) (← links)
• Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms (Q89285568) (← links)
• Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy (Q89775482) (← links)
• Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors (Q92002618) (← links)
• High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187 (TMEM187) Genes: SYTL4- Protein Modeling, Protein-Protein Interaction, Expression Profiling and MicroRNA Studies (Q92027368) (← links)
• Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission (Q92118567) (← links)
• Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment (Q92725689) (← links)
• Synaptophysin sustains presynaptic performance by preserving vesicular synaptobrevin-II levels (Q92875274) (← links)
• Systems biology reveals reprogramming of the S-nitroso-proteome in the cortical and striatal regions of mice during aging process (Q98513674) (← links)